January DCI Seminar Series: Alumna Lori Pierce Speaks on Radiation Oncology & Equity of Care (1.26.22)

Lori Pierce
Lori Pierce, MD, FASCO, FASTRO,

The January 2022 Duke Cancer Institute Seminar Series, to be held on Wednesday, January 26, via Zoom, will feature Lori Pierce, MD, FASCO, FASTRO, vice provost for Academic and Faculty Affairs and professor of Radiation Oncology, University of Michigan.

Pierce, past president and current chair of the Board of the American Society of Clinical Oncology, will present “The Intersection of Quality in Radiation Delivery and Equity of Care."

Pierce, a Duke University School of Medicine alum, completed her Radiation Oncology residency and served as chief resident at the Hospital of the University of Pennsylvania. From 1990 to 1992, she served as a senior investigator at the National Cancer Institute, then joined the faculty of the University of Michigan. She has served as residency director and clinical director in the Department of Radiation Oncology there and in August 2005 was appointed by the University of Michigan Board of Regents to her vice provost role.

Pierce has dedicated her career to the treatment of breast cancer patients. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radio-sensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.

She serves as director of the Michigan Radiation Oncology Quality Consortium (MROQC), a quality consortium of radiation oncology practices across the state of Michigan that seeks to establish best practices in the treatment of breast and lung cancers. This initiative is funded by Blue Cross Blue Shield of Michigan and Blue Care Network.

Pierce is a previous member of the NCI Breast Cancer Steering Committee and has also served on the Steering Committee for the Early Breast Cancer Trialists’ Collaborative Group at the University of Oxford. She continues to serve on many U.S. breast cancer boards and committees and was recently selected to be a member of the Breast Cancer Research Foundation Scientific Advisory Board.

Pierce has published more than 200 manuscripts and book chapters and has received numerous teaching awards from the University of Michigan and multiple national organizations. Honors include receipt of the European Society of Therapeutic Radiology and Oncology travel award, the American Medical Association Women Physician Mentor Award, the American Association for Women Radiologists’ Marie Curie Award, the Conquer Cancer Foundation Endowed Women Who Conquer Cancer Mentorship Award, and selection as a Susan G. Komen for the Cure Scholar.

Pierce was elected to the 2018 class of the National Academy of Medicine. Most recently, she was the recipient of the 2021 Association of Community Cancer Centers Annual Achievement Award. She served as president of the American Society of Clinical Oncology in 2020-21 and is currently board chair.

Pierce's lecture begins at 8 a.m. and ends at 9 a.m. The January 2022 DCI Seminar Series is presented by the DCI Radiation Oncology & Imaging (ROI) Program and is held in conjunction with Hematology Oncology Grand Rounds.

For more information and to access the Zoom link for this talk, email Joan Lofton, MBA, AGM